| Ronald L Lopez, MD | |
|
4439 State Route 159, Ste 120, Chillicothe, OH 45601-8207 | |
| (740) 779-7270 | |
| (740) 779-7279 |
| Full Name | Ronald L Lopez |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 4439 State Route 159, Chillicothe, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457385429 | NPI | - | NPPES |
| 0881176 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35.056496 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adena Regional Medical Center | Chillicothe, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adena Medical Group Llc | 1153456579 | 342 |
News Archive
In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states,This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components.
Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.
There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.
› Verified 8 days ago
| Entity Name | Adena Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235468083 PECOS PAC ID: 1153456579 Enrollment ID: O20100323001007 |
News Archive
In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states,This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components.
Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.
There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald L Lopez, MD 272 Hospital Rd, Suite 3, Chillicothe, OH 45601-9031 Ph: (740) 779-8234 | Ronald L Lopez, MD 4439 State Route 159, Ste 120, Chillicothe, OH 45601-8207 Ph: (740) 779-7270 |
News Archive
In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states,This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components.
Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.
There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that XIAFLEX™ is now available in the U.S. by prescription, for the treatment of adult Dupuytren's contracture patients with a palpable cord. Dupuytren's contracture is a debilitating disease resulting from excessive collagen deposition that causes contractures of the fingers.
› Verified 8 days ago
Dr. Neely Nelson Wade, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159 Ste 120, Chillicothe, OH 45601 Phone: 740-779-7201 | |
Emiley Blake, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159, Ste 120, Chillicothe, OH 45601 Phone: 740-779-7275 Fax: 740-779-7279 | |
Dr. Christopher S Buckley, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159, Ste 120, Chillicothe, OH 45601 Phone: 740-779-7270 Fax: 740-779-7279 | |
Dr. Kristin A Colwell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159, Ste G70, Chillicothe, OH 45601 Phone: 740-779-7201 Fax: 740-779-7206 | |
Richard J Villarreal, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 610 Blackwater Rd, Chillicothe, OH 45601 Phone: 740-642-4400 Fax: 740-642-4407 | |
Catherine Marie Neal, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4439 State Route 159 Ste 120, Chillicothe, OH 45601 Phone: 740-779-7201 Fax: 740-779-7279 |